Related references
Note: Only part of the references are listed.Human immune responses and potential for vaccine assessment in humanized mice
Ramesh Akkina
CURRENT OPINION IN IMMUNOLOGY (2013)
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
Hiroyuki Suzuki et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Safety and immunogenicity of 2010-2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine Results of a randomized trial
David W. Scheifele et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Hypothesis driven development of new adjuvants Short peptides as immunomodulators
Jessica C. Dong et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901
Steffen Walter et al.
ONCOIMMUNOLOGY (2013)
TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis
Evelien Zonneveld-Huijssoon et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy
Valerie Dutoit et al.
BRAIN (2012)
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Elizabeth A. Mittendorf et al.
CANCER (2012)
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
Peggy J. de Vos van Steenwijk et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
First clinical trial of cancer vaccine therapy with artificially synthesized helper/killer-hybrid epitope long peptide of MAGE-A4 cancer antigen
Norihiko Takahashi et al.
CANCER SCIENCE (2012)
Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: A Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders
Jooeun Bae et al.
CLINICAL CANCER RESEARCH (2012)
Rational Design of DNA Vaccines for the Induction of Human Papillomavirus Type 16 E6-and E7-Specific Cytotoxic T-Cell Responses
Koen Oosterhuis et al.
HUMAN GENE THERAPY (2012)
Toxoplasma gondii HLA-B*0702-restricted GRA720-28 peptide with adjuvants and a universal helper T cell epitope elicits CD8+ T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice
Hua Cong et al.
HUMAN IMMUNOLOGY (2012)
A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned
Stephanie Gras et al.
IMMUNOLOGICAL REVIEWS (2012)
The Toxoplasma gondii Peptide AS15 Elicits CD4 T Cells That Can Control Parasite Burden
Harshita Satija Grover et al.
INFECTION AND IMMUNITY (2012)
Trp2 Peptide Vaccine Adjuvanted with (R)-DOTAP Inhibits Tumor Growth in an Advanced Melanoma Model
Elizabeth A. Vasievich et al.
MOLECULAR PHARMACEUTICS (2012)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine
Masato Kono et al.
VACCINE (2012)
A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines
Holly R. Hughes et al.
VIROLOGY (2012)
Multiple linear epitopes (B-cell, CTL and Th) of JEV expressed in recombinant MVA as multiple epitope vaccine induces a protective immune response
Fengjuan Wang et al.
VIROLOGY JOURNAL (2012)
Immunogenicity of a multi-epitope DNA vaccine against hantavirus
Chen Zhao et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines
Mona E. E. Elfaki et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
Samar Hamdy et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
被撤回的出版物: Molecular Mechanism of MART-1+/A*0201+ Human Melanoma Resistance to Specific CTL-Killing Despite Functional Tumor-CTL Interaction (Retracted article. See vol. 77, pg. 3718, 2017)
Ali R. Jazirehi et al.
CANCER RESEARCH (2011)
DNA vaccine expressing repeated carcinoembryonic antigen (CEA)625-667 induces strong immunity in mice
Dan Li et al.
IMMUNOLOGY LETTERS (2011)
Enhancement of DNA vaccine potency by antigen linkage to IFN-γ-inducible protein-10
Tae Heung Kang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
A TCR Targeting the HLA-A*0201-Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer
Nachimuthu Chinnasamy et al.
JOURNAL OF IMMUNOLOGY (2011)
MHC Class II Binding Prediction by Molecular Docking
M. Atanasova et al.
MOLECULAR INFORMATICS (2011)
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Douglas J. Schwartzentruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cross-Protective Peptide Vaccine against Influenza A Viruses Developed in HLA-A*2402 Human Immunity Model
Toru Ichihashi et al.
PLOS ONE (2011)
Towards an immunosense vaccine to prevent toxoplasmosis: Protective Toxoplasma gondii epitopes restricted by HLA-A*0201
Hua Cong et al.
VACCINE (2011)
Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response
Bin Zhou et al.
VIROLOGY JOURNAL (2011)
Bacteria Modulate the CD8+T Cell Epitope Repertoire of Host Cytosol-Exposed Proteins to Manipulate the Host Immune Response
Yaakov Maman et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Results of the First Phase 1 Clinical Trial of the HER-2/neu Peptide (GP2) Vaccine in Disease-Free Breast Cancer Patients
Mark G. Carmichael et al.
CANCER (2010)
Multiple Antigen Peptide Vaccines against Plasmodium falciparum Malaria
Babita Mahajan et al.
INFECTION AND IMMUNITY (2010)
MART-1-Specific Melanoma Tumor-Infiltrating Lymphocytes Maintaining CD28 Expression Have Improved Survival and Expansion Capability Following Antigenic Restimulation In Vitro
Yufeng Li et al.
JOURNAL OF IMMUNOLOGY (2010)
Conservation and Diversity of Influenza A H1N1 HLA-Restricted T Cell Epitope Candidates for Epitope-Based Vaccines
Paul ThiamJoo Tan et al.
PLOS ONE (2010)
Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes
Henrik Kloverpris et al.
AIDS (2009)
T Cell Activation
Jennifer E. Smith-Garvin et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Multiepitope Peptide-Loaded Virus-Like Particles as a Vaccine Against Hepatitis B Virus-Related Hepatocellular Carcinoma
Fei-Xiang Ding et al.
HEPATOLOGY (2009)
Quantitative expression and immunogenicity of MAGE-3 and-6 in upper aerodigestive tract cancer
Pedro A. Andrade Filho et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones
Amir Khammari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
New horizons in adjuvants for vaccine development
Steven G. Reed et al.
TRENDS IN IMMUNOLOGY (2009)
A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+T cells in a Phase I clinical trial in HIV-uninfected adults
Xia Jin et al.
VACCINE (2009)
Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence - From US Military Cancer Institute clinical trials group study I-01 and I-02
Jarrod P. Holmes et al.
CANCER (2008)
Tracking Antigen-Driven Responses by Flow Cytometry: Monitoring Proliferation by Dye Dilution
Paul K. Wallace et al.
CYTOMETRY PART A (2008)
Results of the first phase I clinical trial of the novel Ii-key hybrid preventive HER-2/neu peptide (AE37) vaccine
Jarrod P. Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Positive Selection and Expansion of Cytomegalovirus-specific CD4 and CD8 T Cells in Sealed Systems
Giuseppina Li Pira et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii
Hua Cong et al.
VACCINE (2008)
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice
Majid Golkar et al.
VACCINE (2007)
Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray
DS Chen et al.
PLOS MEDICINE (2005)
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation
AA Jungbluth et al.
BLOOD (2005)
MAGE-A3 is a frequent tumor antigen of metastasized melanoma
C Roeder et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2005)
Prediction of CTL epitopes using QM, SVM and ANN techniques
M Bhasin et al.
VACCINE (2004)
Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1)
KG Kohlgraf et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Application of support vector machines for T-cell epitopes prediction
YD Zhao et al.
BIOINFORMATICS (2003)
Expression of cancer/testis (CT) antigens in lung cancer
K Tajima et al.
LUNG CANCER (2003)
Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2β protein in HLA-transgenic mice and patients
F Garcia et al.
MICROBES AND INFECTION (2003)
Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries
E Beghetto et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2003)
An HMM model for coiled-coil domains and a comparison with PSSM-based predictions
M Delorenzi et al.
BIOINFORMATICS (2002)
Recent developments in adjuvants for vaccines against infectious diseases
DT O'Hagan et al.
BIOMOLECULAR ENGINEERING (2001)
Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules
MH Andersen et al.
TISSUE ANTIGENS (2000)
Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma
CM Chu
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Share Paper
